-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Antibody-Based Strategies As Potential New Treatments for Von Willebrand Disease

Program: Scientific Symposia
Session: Special Symposium on the Basic Science in Hemostasis and Thrombosis
Monday, December 11, 2023, 4:30 PM-6:00 PM

Caterina Casari, PhD

Inserm Uni, Paris, FRA; Unit 1176 Hemostasis, Inflammation and Thrombosis Lab, Inserm, Le Kremlin-Bicetre, France; University Paris-Saclay, Le Kremlin-Bicetre, France

Disclosures: Casari: Takeda France: Consultancy.

OffLabel Disclosure: Emicizumab

See more of: Special Symposium on the Basic Science in Hemostasis and Thrombosis
See more of: Scientific Symposia
<< Previous Presentation | Next Presentation >>